Walmart Inc. is suing many of the nation’s largest pharmaceutical companies, alleging they colluded to inflate the price of ...

Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

A study linking Indian generic drugs to a higher risk of serious side effects in the US has spurred backlash from the Indian ...

The acquired portfolio consists of 13 ANDAs already approved by the Food and Drug Administration and one pending approval.

India, the world’s largest supplier of generic medicines, produces about a fifth of the global supply and its 752 FDA-compliant factories meet roughly 40% of US demand for non-patented medications.

India has a strong pharma network, with more than 10,000 manufacturing facilities, over 3,000 pharma companies.

Mankind Pharma has launched generic versions of diabetes medication Empagliflozin under brand names Empaglyde, Empagreat, and ...

has been making significant strides in the pharmaceutical industry, particularly in the generic drug market. The company has recently shown strong performance across its business segments, reflected ...

The company’s "Generic Revival" strategy appears to be paying off, as evidenced by the strong growth in this segment. In the specialty pharmaceutical space, Amneal is working to establish itself ...